Testing effectiveness (Phase 2)WithdrawnNCT05191004
What this trial is testing
Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC
Who this might be right for
Advanced Breast CancerMetastatic Breast CancerBreast Cancer+5 more
Nuvation Bio Inc.